Pancreatic Cancer Research

Journal articleEur Rev Med Pharmacol Sci2018

MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.

Journal
Eur Rev Med Pharmacol Sci
Published
1 December 2018
Citations
36
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Objective The aim of this study was to explore the role of microRNA-210 (miR-210) and E2F3 in the development of pancreatic cancer and to investigate the possible underlying mechanism. Patients and methods The expression level of miR-210 in pancreatic cancer tissues, para-cancerous tissues, and normal pancreatic tissues was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). … Excerpt only: this text is the publisher’s. Read it in full at the source.